1. Home
  2. CSTE vs MAIA Comparison

CSTE vs MAIA Comparison

Compare CSTE & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CSTE

Caesarstone Ltd.

HOLD

Current Price

$1.34

Market Cap

68.8M

Sector

Industrials

ML Signal

HOLD

Logo MAIA Biotechnology Inc.

MAIA

MAIA Biotechnology Inc.

HOLD

Current Price

$1.49

Market Cap

49.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSTE
MAIA
Founded
1987
2018
Country
Israel
United States
Employees
N/A
N/A
Industry
Building Materials
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
68.8M
49.3M
IPO Year
2012
2022

Fundamental Metrics

Financial Performance
Metric
CSTE
MAIA
Price
$1.34
$1.49
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$5.00
N/A
AVG Volume (30 Days)
98.8K
551.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
29.53
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$1.59
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.86
$0.87
52 Week High
$3.70
$3.19

Technical Indicators

Market Signals
Indicator
CSTE
MAIA
Relative Strength Index (RSI) 27.86 35.97
Support Level $0.86 $1.20
Resistance Level $1.90 $1.69
Average True Range (ATR) 0.22 0.21
MACD -0.08 -0.05
Stochastic Oscillator 6.02 7.62

Price Performance

Historical Comparison
CSTE
MAIA

About CSTE Caesarstone Ltd.

Caesarstone Ltd manufactures engineered quartz surfaces. Its products include engineered quartz and porcelain slabs, which are used as kitchen countertops in renovation and remodeling, and residential construction. It also has other applications, including vanity tops, wall panels, backsplashes, floor tiles, stairs, and other interior surfaces that are used in various residential and non-residential applications. The company sells its products under the Caesarstone brand. Caesarstone's geographical segments are the United States, Canada, Latin America, Australia, Asia, Israel, and EMEA(Europe, Middle East, Africa).

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.

Share on Social Networks: